Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3194773 | Clinics in Dermatology | 2009 | 8 Pages |
Abstract
Cosmetic ingredients previously considered “inert” have potential to provide a biologic effect to skin. In a cosmeceutical formulation, the boundary between an “active” and “inert” ingredient may be obscured. For this reason, the cosmeceutical distributor must find a nonambiguous method to demonstrate the efficacy of a new ingredient. For a product to be successful in the marketplace, the benefits of the product must clearly be communicated to the consumer, and the consumer must be satisfied with product performance.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Karl Lintner, Claire Mas-Chamberlin, Philippe Mondon, Olivier Peschard, Louis Lamy,